BRAF and KRAS gene mutations in intraductal papillary mucinous neoplasm/carcinoma (IPMN/IPMC) of the pancreas
about
EFEMP1 binds the EGF receptor and activates MAPK and Akt pathways in pancreatic carcinoma cellsGenetic and epigenetic alterations in pancreatic carcinogenesisPancreatic cancer from bench to bedside: molecular pathways and treatment optionsDevelopmental Pathways Direct Pancreatic Cancer Initiation from Its Cellular OriginK-Ras promotes angiogenesis mediated by immortalized human pancreatic epithelial cells through mitogen-activated protein kinase signaling pathways.Copy number amplification of the PIK3CA gene is associated with poor prognosis in non-lymph node metastatic head and neck squamous cell carcinoma.High-throughput mutation profiling in intraductal papillary mucinous neoplasm (IPMN).The secret origins and surprising fates of pancreas tumorsMalignant melanoma arising from a perianal fistula and harbouring a BRAF gene mutation: a case report.Molecular pathology of intraductal papillary mucinous neoplasms of the pancreas.Clinicopathological characteristics and molecular analyses of multifocal intraductal papillary mucinous neoplasms of the pancreasMutational analyses of the BRAF, KRAS, and PIK3CA genes in oral squamous cell carcinoma.Diagnostic value of combining CA 19-9 and K-ras gene mutation in pancreatic carcinoma: a meta-analysis.Molecular pathways in pancreatic carcinogenesisIntraductal papillary mucinous neoplasm of the pancreas: an updatePrecursor lesions for sporadic pancreatic cancer: PanIN, IPMN, and MCN.Next generation sequencing improves the accuracy of KRAS mutation analysis in endoscopic ultrasound fine needle aspiration pancreatic lesions.Enhancement of 5-fluorouracil-induced in vitro and in vivo radiosensitization with MEK inhibition.Recurrent GNAS mutations define an unexpected pathway for pancreatic cyst development.KRAS and guanine nucleotide-binding protein mutations in pancreatic juice collected from the duodenum of patients at high risk for neoplasia undergoing endoscopic ultrasound.Intraductal papillary mucinous tumors of the pancreas: biology, diagnosis, and treatment.Cystic precursors to invasive pancreatic cancer.Genetic markers of malignant transformation in intraductal papillary mucinous neoplasm of the pancreas: a meta-analysis.Expansion of epigenetic alterations in EFEMP1 promoter predicts malignant formation in pancreatobiliary intraductal papillary mucinous neoplasmsMultiple genes are hypermethylated in intraductal papillary mucinous neoplasms of the pancreas.Hypermethylation-mediated reduction of WWOX expression in intraductal papillary mucinous neoplasms of the pancreas.Challenges and advances in mouse modeling for human pancreatic tumorigenesis and metastasisLoss of PTEN expression is associated with poor prognosis in patients with intraductal papillary mucinous neoplasms of the pancreas.Mutational analyses of multiple oncogenic pathways in intraductal papillary mucinous neoplasms of the pancreas.Global genomic analysis of intraductal papillary mucinous neoplasms of the pancreas reveals significant molecular differences compared to ductal adenocarcinomaMolecular Biologic Approach to the Diagnosis of Pancreatic Carcinoma Using Specimens Obtained by EUS-Guided Fine Needle Aspiration.Cyst fluid biomarkers for intraductal papillary mucinous neoplasms of the pancreas: a critical review from the international expert meeting on pancreatic branch-duct-intraductal papillary mucinous neoplasms.The genetic classification of pancreatic neoplasia.Pancreatic intraductal tubulopapillary neoplasm is genetically distinct from intraductal papillary mucinous neoplasm and ductal adenocarcinoma.Integration of KRAS testing in the diagnosis of pancreatic cystic lesions: a clinical experience of 618 pancreatic cysts.Loss of expression of the SWI/SNF chromatin remodeling subunit BRG1/SMARCA4 is frequently observed in intraductal papillary mucinous neoplasms of the pancreas.The oncocytic subtype is genetically distinct from other pancreatic intraductal papillary mucinous neoplasm subtypes.Intraductal papillary-mucinous neoplasia of the pancreas: Histopathology and molecular biologyA new approach to managing intraductal papillary mucinous pancreatic neoplasms.Distinct pathways of pathogenesis of intraductal oncocytic papillary neoplasms and intraductal papillary mucinous neoplasms of the pancreas.
P2860
Q24321551-A7379009-940E-40DD-85E3-60E144050380Q24598655-13D2BED8-10AA-428F-B6B0-D9A0AB8C2B09Q26747524-0CC105D1-E0C5-49B4-86C5-FB0EC8F402C5Q26774942-19348E71-6CA0-4CF6-A61F-23AC5727C0BDQ30608512-F3EA9C26-C669-4B6B-9A84-90555BF3456EQ31096247-808B07A3-B5D2-400B-81CB-579120981C61Q33790925-C3578931-EC18-4892-A4CD-1E54B870067BQ33827679-B4D2FD5A-3475-4465-8416-F261DBD39612Q33986593-6C49BE0D-3405-4505-BAA8-C3AFDA16A606Q34008627-9BDB7DFC-C708-4980-92A4-E5B211DD0F62Q34100230-1774A651-8110-4DBF-90BE-4D0F3DC397A0Q34330763-15D15E96-6BB0-44BC-8422-C7F1FD00A48DQ34547888-802A3DC1-8C64-463D-BB21-145E11DB560AQ34640467-B2A8DAF0-D07C-4640-A7F7-9987B7785738Q34657866-0093359C-256D-4DAD-BC2B-818B49EC333EQ34661643-ABFC8AB2-51D2-4BB7-8D3F-78D02BF656DEQ35087934-1064187F-8D75-43A1-93F5-57C51446C0BFQ35146186-1B8A2384-2072-47E0-BBCF-96982658D140Q35178284-9162829E-8114-4DC7-BF2A-8D7A81989FE3Q35498705-0C69B15E-325A-4F27-AA65-F97093D61CFDQ35583848-6DAAFFC7-2442-4472-856C-FD3C03A35088Q35609914-D31CEC7E-2273-4CEC-BA6A-356B110B6F5FQ36849427-5B2C9BFA-BCCB-4A09-A81E-87B8FDDC65F2Q36985263-69B6D187-71CF-4ADA-A632-C0C4263C2E6BQ37183611-A6A2DD6A-C673-42DC-AFE5-078545061867Q37222620-BA622219-FDDB-4D2D-B37C-68880170F12AQ37411831-6CE8F831-975B-4DBB-908B-DA614061E963Q37558614-18A91AAF-14E8-420B-8D22-C66FED710863Q37558631-BB2FE11F-7F2F-449B-92DA-97B8AA8FEA49Q37643001-ADEAB0F6-70E0-453B-8CF5-C6454ECDCB35Q38063856-FD42F331-E3F5-4BC8-ACF3-AFF0BE7017ABQ38319885-4D270439-BF88-4F50-BACD-FFE88336083BQ38326191-50CA9AA4-D8C7-44E5-8325-6BC1C7D97BF1Q38646960-44632BBC-1305-4F43-9430-BD8FA5724930Q39406163-A5CE54E4-B8D6-4019-ABFD-C2C65F4E1989Q39469747-8B121A55-2022-4166-83D7-24825F9B1DE1Q41105157-40E159A8-0785-4A5A-A3D6-83AD1EFCDBC5Q41131015-A058551E-B2DF-42C3-AE23-1FDBB30B64B5Q42409627-51F4D784-D3FB-4F94-BCEF-B162FED4AE89Q42721594-C61990D9-A177-412C-BA44-50B9F9A13216
P2860
BRAF and KRAS gene mutations in intraductal papillary mucinous neoplasm/carcinoma (IPMN/IPMC) of the pancreas
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
BRAF and KRAS gene mutations i ...... ma (IPMN/IPMC) of the pancreas
@ast
BRAF and KRAS gene mutations i ...... ma (IPMN/IPMC) of the pancreas
@en
type
label
BRAF and KRAS gene mutations i ...... ma (IPMN/IPMC) of the pancreas
@ast
BRAF and KRAS gene mutations i ...... ma (IPMN/IPMC) of the pancreas
@en
prefLabel
BRAF and KRAS gene mutations i ...... ma (IPMN/IPMC) of the pancreas
@ast
BRAF and KRAS gene mutations i ...... ma (IPMN/IPMC) of the pancreas
@en
P2093
P2860
P1433
P1476
BRAF and KRAS gene mutations i ...... ma (IPMN/IPMC) of the pancreas
@en
P2093
Frank Schönleben
Gloria H Su
Harold Frucht
John A Chabot
John D Allendorf
Karl C Bruckman
Margaret H Lauerman
Nancy T Ciau
Wanglong Qiu
Xiaojun Li
P2860
P304
P356
10.1016/J.CANLET.2006.09.007
P407
P50
P577
2006-11-09T00:00:00Z